Evidence map›Paper›PMID 26728316›Full record

ArticleRetrovirology2016

HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.

Chi N Chan, Benjamin Trinité, Caroline S Lee, Saurabh Mahajan, Akanksha Anand, Dominik Wodarz, Steffanie Sabbaj, Anju Bansal, Paul A Goepfert, David N Levy

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. A CCR5BMC research notes · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chi N ChanDepartment of Basic Science, New York University College of Dentistry, New York, NY, 10010, USA. cnc7@nyu.edu.
Benjamin TrinitéDepartment of Basic Science, New York University College of Dentistry, New York, NY, 10010, USA. bt32@nyu.edu.
Caroline S LeeDepartment of Basic Science, New York University College of Dentistry, New York, NY, 10010, USA. csl303@nyu.edu.
Saurabh MahajanDepartment of Basic Science, New York University College of Dentistry, New York, NY, 10010, USA. saurabh05@nyu.edu.
Akanksha AnandDepartment of Basic Science, New York University College of Dentistry, New York, NY, 10010, USA. akank.anand@gmail.com.
Dominik WodarzDepartment of Ecology and Evolutionary Biology, University of California, Irvine, School of Biological, Sciences, Irvine, CA, 92697, USA. dwodarz@uci.edu.
Steffanie SabbajDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. sabbaj@uab.edu.
Anju BansalDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. ABansal@uab.edu.
Paul A GoepfertDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. paulg@uab.edu.
David N LevyDepartment of Basic Science, New York University College of Dentistry, New York, NY, 10010, USA. dnlevy@nyu.edu.
New York University · USUniversity of Alabama at Birmingham · USUniversity of California, Irvine · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
HIV-1 Cryptic Epitopes: Implications for Vaccine DesignR01AI084772 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GOEPFERT, PAUL A. · 2009 to 2013
$2.5M
HIV-1 Replication Without IntegrationR01AI078783 · NIAID · NEW YORK UNIVERSITY · PI LEVY, DAVID N · 2009 to 2013
$2.1M
A Rational Approach for HIV Vaccine T Cell Epitope SelectionR01AI112566 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GOEPFERT, PAUL A. · 2014 to 2017
$1.9M
Viruis Dynamics and Multiple Infection of Cells: Computational and Experimental AR01AI093998 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI LEVY, DAVID N, WODARZ, DOMINIK F · 2011 to 2014
$1.5M
The contribution of unintegrated HIV-1 to latency and to models of latencyR56AI118453 · NIAID · NEW YORK UNIVERSITY · PI LEVY, DAVID N · 2015 to 2015
$396k
NIAID NIH HHS AI078783NIAID NIH HHS AI084772NIAID NIH HHS AI093998NIAID NIH HHS AI112566NIAID NIH HHS AI118453NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI078783NIAID NIH HHS R01 AI084772NIAID NIH HHS R01 AI093998NIAID NIH HHS R01 AI112566NIAID NIH HHS R56 AI118453
6 · The paper itself

Abstract

backgroundHIV-1 integration is prone to a high rate of failure, resulting in the accumulation of unintegrated viral genomes (uDNA) in vivo and in vitro. uDNA can be transcriptionally active, and circularized uDNA genomes are biochemically stable in non-proliferating cells. Resting, non-proliferating CD4 T cells are prime targets of HIV-1 infection and latently infected resting CD4 T cells are the major barrier to HIV cure. Our prior studies demonstrated that uDNA generates infectious virions when T cell activation follows rather than precedes infection.

resultsHere, we characterize in primary resting CD4 T cells the dynamics of integrated and unintegrated virus expression, genome persistence and sensitivity to latency reversing agents. Unintegrated HIV-1 was abundant in directly infected resting CD4 T cells. Maximal gene expression from uDNA was delayed compared with integrated HIV-1 and was less toxic, resulting in uDNA enrichment over time relative to integrated proviruses. Inhibiting integration with raltegravir shunted the generation of durable latency from integrated to unintegrated genomes. Latent uDNA was activated to de novo virus production by latency reversing agents that also activated latent integrated proviruses, including PKC activators, histone deacetylase inhibitors and P-TEFb agonists. However, uDNA responses displayed a wider dynamic range, indicating differential regulation of expression relative to integrated proviruses. Similar to what has recently been demonstrated for latent integrated proviruses, one or two applications of latency reversing agents failed to activate all latent unintegrated genomes. Unlike integrated proviruses, uDNA gene expression did not down modulate expression of HLA Class I on resting CD4 T cells. uDNA did, however, efficiently prime infected cells for killing by HIV-1-specific cytotoxic T cells.

conclusionsThese studies demonstrate that contributions by unintegrated genomes to HIV-1 gene expression, virus production, latency and immune responses are inherent properties of the direct infection of resting CD4 T cells. Experimental models of HIV-1 latency employing directly infected resting CD4 T cells should calibrate the contribution of unintegrated HIV-1.

Indexed as

Virus LatencyVirus ReplicationAdultCD4-Positive T-LymphocytesCells, CulturedDNA, ViralGene Expression ProfilingHIV-1HumansTranscription, GeneticDNA, Viral

Identifiers

PMID26728316
PMCPMC4700562
OpenAlexW2223239026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.